Manager NewsPrivate Credit

OrbiMed creates debt facility for pharmaceutical firm

OrbiMed Advisors led the completion of a $200 million debt facility for Harmony Biosciences, a firm that develops treatment options for people living with rare diseases. The financing is slated to support the company’s commercialization of the narcolepsy treatment WAKIX (pitosilant) in the U.S. The U.S. Food and Drug Administration approved the product in August …

GET THE FULL STORY

Continue reading this article with an annual or monthly subscription. One low price gets you instant access to:

  • All new and archived articles
  • Mandate charts
  • Daily, weekly & monthly newsletters

Start Reading

Related Articles

Back to top button
Close